###begin article-title 0
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 103 111 <span type="species:ncbi:9606">Patients</span>
Murine Leukemias with Retroviral Insertions at Lmo2 Are Predictive of the Leukemias Induced in SCID-X1 Patients Following Retroviral Gene Therapy
###end article-title 0
###begin p 1
Conceived and designed the experiments: UPD. Performed the experiments: UPD RT SMC. Analyzed the data: UPD NAJ NGC. Contributed reagents/materials/analysis tools: UPD KA MAT MY RS JRD NAJ NGC. Wrote the paper: UPD NAJ NGC.
###end p 1
###begin p 2
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 931 935 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 440 446 <span type="species:ncbi:10090">murine</span>
###xml 528 533 <span type="species:ncbi:9606">human</span>
###xml 632 640 <span type="species:ncbi:9606">patients</span>
###xml 887 892 <span type="species:ncbi:10090">mouse</span>
###xml 897 902 <span type="species:ncbi:9606">human</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 998 1003 <span type="species:ncbi:9606">human</span>
Five X-linked severe combined immunodeficiency patients (SCID-X1) successfully treated with autologous bone marrow stem cells infected ex vivo with an IL2RG-containing retrovirus subsequently developed T-cell leukemia and four contained insertional mutations at LMO2. Genetic evidence also suggests a role for IL2RG in tumor formation, although this remains controversial. Here, we show that the genes and signaling pathways deregulated in murine leukemias with retroviral insertions at Lmo2 are similar to those deregulated in human leukemias with high LMO2 expression and are highly predictive of the leukemias induced in SCID-X1 patients. We also provide additional evidence supporting the notion that IL2RG and LMO2 cooperate in leukemia induction but are not sufficient and require additional cooperating mutations. The highly concordant nature of the genetic events giving rise to mouse and human leukemias with mutations at Lmo2 are an encouraging sign to those wanting to use mice to model human cancer and may help in designing safer methods for retroviral gene therapy.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 646 650 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 865 869 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 1097 1102 <span type="species:ncbi:9606">human</span>
###xml 1125 1130 <span type="species:ncbi:10090">mouse</span>
Twenty patients with X-linked severe combined immunodeficiency (SCID-X1) have been successfully treated by gene therapy. Unfortunately, five of these patients have developed T-cell leukemia two or more years after receiving the therapeutic gene IL2RG on a retroviral vector. The leukemias developed because the vector inserted itself near cancer-causing genes and disrupted their normal regulation. Remarkably, in four patients, the vector inserted near a known T-cell oncogene, LMO2. We have found that in mice, similar retroviruses cause T-cell leukemias by inserting near Lmo2. We have found two leukemias that have retroviral insertions near Lmo2 and Il2rg in the same cell. The probability of these insertions happening by chance is exceedingly small and these results imply that these two genes are deregulated together to induce leukemia. Our data show that Lmo2 and Il2rg cooperate but may not be sufficient for leukemia development and additional mutations contribute to leukemia development. We have also found cooperating retroviral insertions in genes that are abnormally expressed in human T-cell leukemias. The mouse models provide unique insight into the pathogenesis of T-cell leukemia, and they are highly predictive of the leukemias caused by SCID-X1 gene therapy.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 88 93 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 95 98 91 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Kovanen1">[1]</xref>
###xml 129 130 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 258 263 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 606 623 602 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LIM domain Only 2</italic>
###xml 625 629 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 631 634 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina1">[2]</xref>
###xml 635 638 631 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina2">[3]</xref>
###xml 639 642 635 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Deichmann1">[4]</xref>
###xml 643 646 639 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Howe1">[5]</xref>
###xml 648 652 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 674 677 670 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Nam1">[6]</xref>
###xml 861 862 857 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1028 1032 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 1074 1077 1070 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Nam1">[6]</xref>
###xml 1078 1081 1074 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-PikeOverzet1">[7]</xref>
###xml 1237 1240 1233 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Wu1">[8]</xref>
###xml 1242 1246 1238 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 1391 1395 1387 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 1452 1456 1448 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 1461 1466 1457 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1490 1493 1486 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dave1">[9]</xref>
###xml 1645 1650 1641 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1691 1695 1687 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 1703 1708 1699 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 1751 1754 1747 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina2">[3]</xref>
###xml 1788 1793 1784 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1937 1941 1933 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-PikeOverzet2">[10]</xref>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 210 239 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 882 890 <span type="species:ncbi:9606">patients</span>
###xml 1018 1026 <span type="species:ncbi:9606">patients</span>
###xml 1399 1405 <span type="species:ncbi:10090">murine</span>
###xml 1765 1770 <span type="species:ncbi:10090">mouse</span>
SCID-X1 patients are deficient in the common gamma chain of the interleukin-2 receptor (IL2RG) [1]. In three SCID-X1 trials, CD34+ hematopoietic stem cells were cultured ex vivo and transduced with a defective Moloney murine leukemia virus (MuLV) expressing IL2RG and then transplanted back to the patients. The possibility that retroviral gene therapy could induce cancer through insertional mutagenesis had been widely discussed but until these trials no cases had been reported. Among the five leukemias that have occurred (four in the French and one in the UK trial), four had insertional mutations at LIM domain Only 2 (LMO2) [2],[3],[4],[5]. LMO2 is a T-cell oncogene [6], suggesting that these leukemias resulted from insertional mutagenesis. SCID-X1 is caused, in part, by a failure of T-cell production, and the infusion of immature gene-corrected CD34+ cells into SCID-X1 patients favors the engraftment of the T-cell lineage over other lineages. This could explain why T-cell leukemias predominate in these patients. LMO2 is also expressed early in hematopoiesis [6],[7] which makes it a good target for insertional mutagenesis since retroviruses like to preferentially integrate near the 5' end of actively transcribed genes [8]. LMO2 is not the only T-cell oncogene expressed during early hematopoiesis, however, indicating there must be other reasons that favor mutagenesis of LMO2. A murine T-cell leukemia with insertional mutations at Lmo2 and Il2rg has also been reported [9]. The probability of finding insertional mutations in both genes by chance in the same leukemia is exceedingly small and has led to the suggestion that Il2rg is a leukemia gene that cooperates with Lmo2. While IL2RG is not overexpressed in SCID-X1 leukemias [3] or in the mouse leukemia with an Il2rg insertion, subtle effects on its expression, such as an inability to downregulate its expression during T cell development, could be oncogenic [10].
###end p 6
###begin p 7
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 182 185 182 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dave1">[9]</xref>
###xml 441 444 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina2">[3]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina3">[11]</xref>
###xml 70 77 <span type="species:ncbi:9606">patient</span>
###xml 108 115 <span type="species:ncbi:9606">patient</span>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
Given the large number of IL2RG-infected cells transplanted into each patient, there is ample chance that a patient would receive a cell that contains an insertional mutation at LMO2[9]. Why then don't all patients develop leukemia? The most likely explanation is that other cooperating mutations are needed for leukemia to occur. Consistent with this, leukemias take several years to develop and contain mutations in other T-cell oncogenes [3],[11].
###end p 7
###begin p 8
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 108 114 <span type="species:ncbi:10090">murine</span>
###xml 374 379 <span type="species:ncbi:9606">human</span>
###xml 427 433 <span type="species:ncbi:10090">murine</span>
###xml 502 508 <span type="species:ncbi:10090">murine</span>
###xml 577 585 <span type="species:ncbi:9606">patients</span>
To provide further insights into this problem we cloned and sequenced the retroviral integrations from five murine leukemias containing insertional mutations at Lmo2 using high-throughput ligation-mediated PCR (LM-PCR)/sequencing method that makes it possible to identify most of the insertionally mutated genes in these leukemias. We then compared the microarray data from human leukemias with upregulated LMO2 expression and murine leukemias with insertional mutations at Lmo2. Our studies show that murine leukemias are highly predictive of the leukemias induced in SCID-X1 patients. They also support a model whereby deregulated IL2RG and LMO2 expression cooperate to induce leukemia but are not sufficient and require other cooperating mutations.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 5 11 <span type="species:ncbi:10090">Murine</span>
Five Murine Leukemias with Insertional Mutations at Lmo2
###end title 10
###begin p 11
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 127 130 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dave1">[9]</xref>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 481 484 481 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina2">[3]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Rabbitts1">[12]</xref>
###xml 491 500 491 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g001">Figure 1A</xref>
###xml 557 566 557 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g001">Figure 1A</xref>
###xml 654 663 654 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g001">Figure 1A</xref>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 76 82 <span type="species:ncbi:10090">murine</span>
###xml 388 395 <span type="species:ncbi:9606">patient</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
The mouse Retroviral Tagged Cancer Gene Database (RTCGD) () lists four AKXD murine leukemias with insertional mutations at Lmo2[9], in addition to the AKXD leukemia analyzed previously which contains insertional mutations at Lmo2 and Il2rg. All of the Lmo2 insertions are located 5' of coding exons 4-6 and are in the same general location as the insertions identified at LMO2 in SCID-X1 patient leukemias and the chromosomal breakpoints at LMO2 identified in sporadic human T-ALL [3],[12] (Figure 1A). Southern analysis showed these insertions are clonal (Figure 1A, bottom left panel, data not shown) and contain 2-4 clonal retroviral insertions each (Figure 1A, bottom right panel), as would be expected if they harbor mutations in Lmo2-cooperating genes.
###end p 11
###begin title 12
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
AKXD Leukemias have frequent clonal Lmo2 insertions of T-cell origin.
###end title 12
###begin p 13
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 568 571 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 749 752 749 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 1074 1077 1074 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 1098 1104 1098 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J&#946;1</italic>
###xml 1152 1155 1149 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 1191 1197 1188 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J&#946;1</italic>
###xml 1346 1350 1340 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
A) The mouse Lmo2 gene is shown above the human gene and the five independent viral insertions cloned from AKXD tumors indicated with red arrows. Tumor names are shown above the arrows. The human LMO2 gene has six exons; gray exons are noncoding and yellow are coding. The bracket indicates chromosomal breakpoints in T-ALL involving 11p13. LMO2 was also insertionally activated in four SCID-X gene therapy patients. Only data for patients 4 and 5 from the French trial are available. Red arrows indicate the site and orientation of gene therapy vector insertion. The BamHI sites used for Southern analysis and the positions of probes (A, B, C) are shown. Molecular weight markers are shown to the left of the blots. Retroviral insertions introduce BamHI sites and show a rearranged band indicated with red asterisks. The germline bands were verified by Southern analysis of genomic DNA from brain and indicated G. The blot on the right was done using a probe (p15E) specific to the ecotropic envelope. B) Southern blots using probes specific for immunoglobulin heavy chain Igh and T-cell receptor Jbeta1 genes are shown with molecular weight markers. Igh shows a 6 kb germline band and the Jbeta1 blot shows a 5.8 kb germline band. The other bands indicate rearrangements that confirm the monoclonality of the tumors. C) Immunohistochemistry of Lmo2-clonal tumors 3095, 7105, and 7107 is shown. The H&E stain shows homogeneous appearing blast cells that have infiltrated and effaced the lymph nodes. All three tumors show mild CD3 staining and mild (3095) to moderate (7105) B220 staining.
###end p 13
###begin p 14
###xml 46 49 46 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dave1">[9]</xref>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 145 151 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J&#946;1</italic>
###xml 168 177 165 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g001">Figure 1B</xref>
###xml 296 299 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 344 353 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g001">Figure 1B</xref>
###xml 355 361 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J&#946;2</italic>
###xml 426 435 420 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g001">Figure 1C</xref>
###xml 487 491 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 508 512 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Larson1">[13]</xref>
###xml 564 568 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Martin1">[14]</xref>
###xml 240 245 <span type="species:ncbi:10090">mouse</span>
###xml 492 507 <span type="species:ncbi:10090">transgenic mice</span>
###xml 525 530 <span type="species:ncbi:9606">human</span>
Tumors 98-031 and 86-277 are T cell in origin [9]. Tumors 7105 and 7107 are also likely to be T cell as they have clonal Igh and T-cell receptor Jbeta1 rearrangements (Figure 1B). The origin of tumor 3095 is unclear. It was isolated from a mouse with thymomegaly and lymphadenopathy and contains Igh but no T-cell receptor gene rearrangements (Figure 1B, Jbeta2 not shown). Tumors 3095 and 7105 showed aberrant B220 staining (Figure 1C), which has been seen before in T-cell tumors from Lmo2 transgenic mice [13] and in some human T-ALLs expressing B-cell markers [14].
###end p 14
###begin title 15
Large-Scale Cloning and Sequencing of Viral Integration Sites
###end title 15
###begin p 16
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Wu1">[8]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Siebert1">[15]</xref>
###xml 417 424 417 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000491-t001">Table 1</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Suzuki1">[16]</xref>
###xml 589 599 589 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s008">Dataset S1</xref>
###xml 733 743 733 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s008">Dataset S1</xref>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
To identify genes that might cooperate with Lmo2 in tumor induction we adapted an LM-PCR method to amplify the other viral insertions present in the five AKXD leukemias [8],[15]. Following nested PCR using virus-specific and adaptor-specific primers, the amplified products were shotgun cloned. The inserts were then sequenced and BLAST-searched against the mouse genome and nearby candidate cancer genes identified (Table 1). These data were then combined with a less robust data set generated using inverse PCR (IPCR) [16]. This analysis identified 84 insertions in the five tumors (see Dataset S1). The percentage of cells in a tumor that harbor an insertion can be estimated from the number of shotgun clones isolated (Freq % in Dataset S1). Insertions present in all tumor cells will be enriched during PCR relative to insertions present in only a fraction of tumor cells and will thus be overrepresented in the shotgun library.
###end p 16
###begin title 17
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
Annotated common insertion sites found by LM-PCR/shotgun cloning of AKXD Lmo2 tumors.
###end title 17
###begin p 18
Genes nearest the sites are shown below the tumor names. Predicted or known protein function and the distance and orientation of the insertions with respect to the nearby gene are shown. All these insertions are CIS in the RTCGD (see text).
###end p 18
###begin p 19
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;39</sup>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000491-t001">Table 1</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Suzuki1">[16]</xref>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;37</sup>
###xml 444 452 444 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s006">Table S1</xref>
###xml 454 464 454 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s008">Dataset S1</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Futreal1">[17]</xref>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 359 364 <span type="species:ncbi:9606">human</span>
Remarkably, 35 insertions are located at common insertion sites (CISs), a highly significant result (Fisher's exact test p = 7.4x10-39) (Table 1). CISs are regions in the genome that are mutated by viral insertion at a rate higher than predicted by random chance and are thus likely to harbor a cancer gene [16]. Thirty-one of these genes are also mutated in human cancer, another highly significant result (Fisher's exact test p = 5.7x10-37) (Table S1, Dataset S1) [17]. This strongly suggests that some of these genes are Lmo2-cooperating genes.
###end p 19
###begin title 20
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
A Second Tumor with an Insertion at Il2rg
###end title 20
###begin p 21
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 56 63 56 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000491-t001">Table 1</xref>
###xml 126 135 126 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g002">Figure 2A</xref>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 273 275 273 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s007">Text S1</xref>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 356 365 356 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g002">Figure 2B</xref>
###xml 414 416 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Johnston1">[18]</xref>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 732 737 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 780 785 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 857 861 857 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 912 921 912 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g002">Figure 2B</xref>
###xml 980 984 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 1098 1103 1098 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1150 1159 1150 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g002">Figure 2B</xref>
###xml 1269 1273 1269 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 1308 1313 1308 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1357 1366 1357 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s004">Figure S4</xref>
###xml 1377 1381 1377 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 1475 1480 1475 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1576 1579 1576 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dave1">[9]</xref>
###xml 1581 1586 1581 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1626 1635 1626 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s003">Figure S3</xref>
###xml 1773 1782 1773 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g002">Figure 2C</xref>
###xml 1822 1827 1822 1827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 1917 1922 1917 1922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1928 1937 1928 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g002">Figure 2A</xref>
###xml 1998 2003 1998 2003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 2085 2090 2085 2090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 2092 2097 2092 2097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 2199 2204 2199 2204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 2230 2239 2230 2239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s003">Figure S3</xref>
###xml 2292 2297 2292 2297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 2323 2328 2323 2328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 2402 2407 2402 2407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 2422 2427 2422 2427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2ra</italic>
###xml 2429 2434 2429 2434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il4ra</italic>
###xml 2436 2439 2436 2439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il7</italic>
###xml 2441 2445 2441 2445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak1</italic>
###xml 2447 2456 2447 2456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5a/5b</italic>
###xml 158 164 <span type="species:ncbi:10090">murine</span>
###xml 1229 1234 <span type="species:ncbi:10090">mouse</span>
Surprisingly, tumor 7107 contains two Il2rg insertions (Table 1), which was confirmed by conventional cloning and sequencing (Figure 2A). Thus, 2 of the AKXD murine leukemias with insertions at Lmo2 also contain insertions at Il2rg, a highly significant result (p = 1.34x10-9, see Text S1 for calculation). Likewise, tumor 7107 has two insertions at Irs2 (Figure 2B), another highly significant result (p = 1.16x10-5, see Text S1 for calculation). Il2rg and Irs2 are functionally linked in lymphoid cells where it has been shown that Il2rg can promote the phosphorylation of Irs2 by binding to and activating the tyrosine kinase Jak3 [18], which may explain the co-selection for mutations in these genes. To quantitate the Irs2 and Il2rg insertions, we amplified one Lmo2 and one Il2rg insertion using insertion-site-specific primers and real time PCR. The Irs2 insertion was present at about one copy per cell (Figure 2B), indicating it is present in every tumor cell. The other Irs2 insertion must therefore be in the same tumor cell, either on the same or different chromosome. In contrast, the Il2rg insertion was present at 0.5 copies per cell (Figure 2B), suggesting it is present in only half the tumor cells of this male mouse. We ruled out hyperploidy for the Irs2 locus and also confirmed that the Il2rg gene was present at one copy per cell (see Figure S4). The two Irs2 insertions must therefore have occurred first and in the same tumor cell followed by the two Il2rg insertions in different subpopulations of tumor cells. Similar to what was reported previously [9], Il2rg is not misexpressed in tumor 7107 (see Figure S3). Most of the genes that were insertionally mutated in this tumor were also highly overexpressed when compared to normal thymus control (Figure 2C). Since our prior study, exons for the Med12 gene were annotated and are shown to direct transcription in the opposite orientation to Il2rg (see Figure 2A). All the tumors have insertions in the same orientation to Med12 except tumor 98-031 and one of the insertions disrupts the second coding exon of Med12. Med12 was not found to be up-regulated in the tumors and no spliced fusion transcript between provirus and Med12 could be identified (see Figure S3). It is conceivable that these insertions implicate Med12 in tumorigenesis and not Il2rg, however, the RTCGD contains many common insertion sites in genes of the Il2rg pathway (e.g. Il2ra, Il4ra, Il7, Jak1, Stat5a/5b).
###end p 21
###begin title 22
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
Tumor 7107 has two independent insertions in Il2rg and Irs2 genes.
###end title 22
###begin p 23
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 514 518 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 616 620 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 897 902 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 914 923 914 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s004">Figure S4</xref>
###xml 1125 1126 1125 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 780 785 <span type="species:ncbi:10090">mouse</span>
###xml 986 991 <span type="species:ncbi:10090">mouse</span>
A) LM-PCR identified two independent insertions in tumor 7107, 5' of the eight coding exons of the Il2rg gene. The two viral chromosomal junctions were independently cloned and sequenced. The insertions were 396 bp apart and should be present in the same clone if they occurred on the same chromosome. Partial sequence for clone 23-10 shows the region of identity with clone 23-1 (green). For clone 23-1, we found viral sequence 5' of this region instead of chromosome X genomic sequence. B) Two insertions in the Irs2 gene were also isolated from the same tumor. Primers were designed for one allelic insertion for Irs2 and Il2rg and real time PCR performed on the genomic DNA. Primers for a chromosome X sequence were used as reference and show a copy number of 1 for this male mouse. As shown, each insertion comprises about 50% of total tumor genomic DNA. We ruled out polyploidy for Irs2 and Il2rg genes (see Figure S4). C) Panel shows a heat map of gene expression data using the mouse Affymetrix array. The expression of genes near high frequency insertions cloned from 7107 is shown with respect to normal thymus. Log2 intensity scale is shown under the heat map.
###end p 23
###begin title 24
Other Multiply Mutated Genes
###end title 24
###begin p 25
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 219 228 219 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g003">Figure 3A</xref>
###xml 278 287 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g003">Figure 3A</xref>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 462 468 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 477 486 477 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g003">Figure 3A</xref>
###xml 618 624 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM16</italic>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Du1">[19]</xref>
###xml 597 602 <span type="species:ncbi:9606">human</span>
Several other genes are also mutated more than once in the Lmo2 tumors, indicating that they might also represent Lmo2-cooperating genes. Two tumors have insertions in the leukemia transcription factor oncogene Prdm16 (Figure 3A) but only the insertion in tumor 7107 is clonal (Figure 3A, bottom left panel). Quantitative RT-PCR/sequencing revealed marked upregulation of a Prdm16 fusion transcript in tumor 7107 that initiates in the viral 5'LTR and splices to Prdm16 exon 2 (Figure 3A, bottom right panel). This transcript is predicted to encode a truncated protein similar to that expressed in human leukemias with PRDM16 mutations [19].
###end p 25
###begin title 26
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
Prdm16 and Mef2c genes are frequently insertionally mutated in AKXD Lmo2 tumors.
###end title 26
###begin p 27
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 266 272 266 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 613 615 613 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bg</italic>
###xml 777 782 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
A) The Prdm16 gene was targeted in tumors 7105 and 7107. Coding exons are in yellow. Tumor 7107 had a clonal insertion as shown by the Southern blot. G shows germline bands and a red asterisk shows the rearrangement. The graph shows quantitative RT-PCR analysis for Prdm16. Real time PCR was normalized to expression in normal thymus. Tumor 7107 had a viral fusion transcript spliced from the 5'LTR to exon 2. The transcript from tumor 7105 was not recovered from the RNA since the insertion was subclonal. B) The Mef2c gene was insertionally activated in three tumors, 3095, 7105, and 98031. Southern blot using BglII-digested genomic DNA using the probe (thick line) shows all insertions were clonal and early in tumorigenesis. Quantitative RT-PCR shows the up-regulation of Mef2c.
###end p 27
###begin p 28
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 64 73 64 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g003">Figure 3B</xref>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox4</italic>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Du2">[20]</xref>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox4</italic>
###xml 263 272 263 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g003">Figure 3B</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 493 502 493 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g003">Figure 3B</xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Du2">[20]</xref>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 647 656 647 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g003">Figure 3B</xref>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 733 740 733 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000491-t001">Table 1</xref>
###xml 816 820 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Bartholomew1">[21]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Lazo1">[22]</xref>
###xml 863 868 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 933 938 933 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 965 970 965 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 977 981 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 1086 1091 1086 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 1109 1113 1109 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox4</italic>
Remarkably, 3 tumors also have insertions in intron 2 of Mef2c (Figure 3B, top panel), which is a transcription factor oncogene that cooperates with Sox4 in leukemia induction [20]. All insertions are in the same transcriptional direction as Sox4 and are clonal (Figure 3B, bottom left panel). Quantitative RT-PCR/sequencing revealed high expression of Mef2c fusion transcripts in these tumors. The transcripts all initiated in the viral 5'LTR and spliced into the first coding exon of Mef2c (Figure 3B, bottom right panel), similar to what is reported for other leukemias with Mef2c insertions [20]. Tumor 7107 also showed high Mef2c expression (Figure 3B, bottom right panel) and has an insertion located 390 kb upstream of Mef2c (Table 1). There is precedent for long-range enhancer effects exerted by proviruses [21],[22], potentially accounting for the high Mef2c expression. Thus, 4 of 5 AKXD tumors have insertions at or near Mef2c, strongly suggesting that Mef2c is an Lmo2-cooperating oncogene. Consistent with this, tumors 98-031, 7105 and 86-277 also had insertions near the Mef2c-cooperating gene Sox4, although only the insertion in tumor 7105 was clonal (data not shown).
###end p 28
###begin p 29
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B3gntl1</italic>
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000491-t001">Table 1</xref>
Finally, tumors 98-031 and 7105 have insertions in the 5' end of the putative acetylglucosaminyltransferase gene, B3gntl1 (Table 1). Very little is known about this gene so the significance of this result is unclear.
###end p 29
###begin title 30
Mutations in E2A-Related Genes
###end title 30
###begin p 31
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcfe2a</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF3</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000491-t001">Table 1</xref>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF3</italic>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Armstrong1">[23]</xref>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF12</italic>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR4A3</italic>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Sjogren1">[24]</xref>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 428 437 428 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g004">Figure 4A</xref>
###xml 535 540 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 549 558 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g004">Figure 4B</xref>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 796 804 796 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 844 853 844 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g004">Figure 4C</xref>
###xml 1116 1125 1116 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g004">Figure 4C</xref>
###xml 72 78 <span type="species:ncbi:9606">humans</span>
###xml 1035 1041 <span type="species:ncbi:9986">rabbit</span>
We also identified insertions in two E2A-related genes, Tcfe2a (TCF3 in humans) and Tcf12 (Table 1), suggesting a role for E2A-related genes in the Lmo2 tumors (p = 0.008). TCF3 is translocated to a number of fusion partners in pre- and pro-B-ALL [23], while TCF12 is fused to NR4A3 in extraskeletal mixoid chondrosarcoma [24]. The Tcf12 insertion is located in intron 5 and is in the same transcriptional orientation as Tcf12 (Figure 4A). 5'RACE showed that it induces a fusion transcript, which initiates in the 5'LTR and splices to Tcf12 exon 9 (Figure 4B). The first ATG is located in exon 9 and is in-frame with Tcf12 coding sequences. Assuming this is the preferred translational start site, the predicted polypeptide would lack 219 residues from the amino terminus, which was confirmed by in vitro transcription and translation studies (Figure 4C, left panel). The major polypeptide migrated at 55 kDa, similar to its predicted mass of 52 kDa. A faint 50-kDa band was also observed. Both proteins were immunoprecipitated with a rabbit polyclonal antibody specific to Tcf12, confirming they are Tcf12-derived (Figure 4C, right panel). The smaller protein could arise from an alternate translational initiation site or be due to protein degradation.
###end p 31
###begin title 32
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
Tcf12 insertion creates a truncated protein.
###end title 32
###begin p 33
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 777 779 777 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1072 1076 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 1178 1182 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gm2a</italic>
###xml 1276 1282 1276 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 1307 1311 1307 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
A) Top panel shows the mouse Tcf12 gene with arrows indicating the ubiquitous promoter and an alternate promoter found in thymus (Alt). Yellow exons are coding and the red arrow indicates the retroviral insertion cloned from tumor 3095. B) Panel shows the sequence of the viral fusion transcript cloned by RT-PCR from this tumor. 5'RACE showed transcription was initiated in the viral 5'LTR and spliced into exon 9. The partial sequence of the viral fusion transcript is shown. Red indicates viral sequences, LTR and 5' of gag. Yellow denotes the start of exon 9 of Tcf12. The first ATG codon (blue) is in frame with the rest of Tcf12. C) Panel shows two SDS-PAGE blots: left panel shows in vitro transcription and translation of the cloned viral fusion cDNA with radiolabeled 35S-methionine. A strong band at 55 kDa appears as well a weaker band at 50 kDa. The in vitro translated proteins were derived from Tcf12 since they were immunoprecipitated with an antibody specific to the protein's COOH-terminus (right panel). D) This heat map shows microarray analysis of the Lmo2-clonal tumors with selected E2A targets. The genes shown are normally up-regulated by E2A except for Gm2a which is repressed. Included in the comparison is tumor 7065 which had a clonal insertion in Notch1 and no up-regulation of Lmo2.
###end p 33
###begin p 34
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Massari1">[25]</xref>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
Tcf12 and Tcfe2a are class I bHLH transcription factors. The amino terminus of Tcf12 encodes two transactivation domains, AD1 and AD2. AD1 is similar to AD1 of the related E2A proteins, which has been shown to have greater potency in transactivation than AD2 [25]. While there are no mutagenesis data on the homologous domains of Tcf12, the truncated Tcf12 transcript expressed in tumor 3095 would lack the AD1 domain but have an intact AD2 domain, which could result in attenuated transactivation.
###end p 34
###begin p 35
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Schwartz1">[26]</xref>
###xml 158 167 158 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g004">Figure 4D</xref>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 317 326 317 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g004">Figure 4D</xref>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gfi1b</italic>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2A</italic>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gm2a</italic>
###xml 488 491 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2A</italic>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
Microarray analysis showed there was considerable differential expression of E2A target transcripts when the five tumors were compared to normal thymus [26] (Figure 4D). Similar, but somewhat less, differential expression, was observed when the tumors were compared with tumor 7065, which has an insertion at Notch1 (Figure 4D). With the exception of Gfi1b, targets activated by E2A are poorly expressed as expected if E2A signaling is attenuated. Conversely, Gm2a, which is repressed by E2A, was highly expressed. These results provide further evidence that the E2A pathway is attenuated in tumors with mutations at Lmo2.
###end p 35
###begin p 36
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tal1</italic>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 199 208 199 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s001">Figure S1</xref>
Microarray expression analysis also showed that these tumors express Tal1 as well as the other experimentally verified Lmo2 binding partners, consistent with the involvement of Lmo2 in these tumors (Figure S1).
###end p 36
###begin title 37
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 52 57 <span type="species:ncbi:9606">Human</span>
Insertionally Mutated Genes Are Highly Expressed in Human T-ALL with High LMO2 Expression
###end title 37
###begin p 38
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Ferrando1">[27]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Chiaretti1">[28]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Yeoh1">[29]</xref>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 642 646 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 928 932 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 945 954 945 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s002">Figure S2</xref>
###xml 1026 1035 1026 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s002">Figure S2</xref>
###xml 1063 1065 1063 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1092 1094 1092 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1123 1125 1123 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 71 77 <span type="species:ncbi:10090">murine</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
###xml 272 278 <span type="species:ncbi:10090">murine</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 697 704 <span type="species:ncbi:9606">patient</span>
###xml 909 915 <span type="species:ncbi:10090">murine</span>
To provide additional evidence that the genes insertionally mutated in murine Lmo2 tumors are causally associated with human T-ALL, we examined the raw data from three large human T-ALL microarray data sets (total of 118 cases) [27],[28],[29] and asked whether any of the murine genes are deregulated in human T-ALL with high LMO2 expression. We separated the human T-ALL cases into LMO2-high and LMO2-low expression classes and performed clustering analysis to identify the genes differentially expressed in the LMO2-high class (p<0.001 significance level). The data sets were remarkably consistent in the genes that were upregulated in the LMO2-high class, despite different array platforms and patient heterogeneity. When genes that were consistently deregulated in the LMO2-high class were queried against the RTCGD, a statistically significant number were located at CISs or are insertionally mutated in murine tumors with Lmo2 insertions (Figure S2), and the number of such genes is much higher than expected by chance (Figure S2; Ferrando et al, p = 1.1x10-3 and Yeoh et al, p = 1.1x10-3; Chiaretti et al, p = 4.1x10-6).
###end p 38
###begin p 39
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEF2C</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 89 98 89 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g005">Figure 5A</xref>
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LAPTM5</italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NMYC</italic>
###xml 409 418 409 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g005">Figure 5A</xref>
###xml 421 427 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5A</italic>
###xml 456 462 456 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5a</italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 794 803 794 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000491-g005">Figure 5B</xref>
###xml 201 206 <span type="species:ncbi:9606">human</span>
###xml 499 505 <span type="species:ncbi:10090">murine</span>
###xml 695 700 <span type="species:ncbi:10090">mouse</span>
Remarkably, MEF2C was overexpressed in the LMO2-high group in all three T-ALL data sets (Figure 5A). This is extremely unlikely to have occurred by chance and further confirms the role of this gene in human T-ALL. Likewise, LAPTM5, which is the site of an insertion in tumor 7107, was identified in all three data sets, while NMYC, an insertion site in tumor 7105, was identified in two microarray data sets (Figure 5A). STAT5A was found in two data sets. Stat5a is not insertionally mutated in the murine tumors but it is a validated leukemia gene and functions in the same signaling pathway as IL2RG. Most of the genes that clustered with the LMO2-high class were also highly expressed in the mouse tumors and some showed differential expression in comparison to normal thymus or tumor 7065 (Figure 5B).
###end p 39
###begin title 40
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human microarray studies show consistent high-level expression of genes and pathways insertionally mutated in AKXD Lmo2 tumors.
###end title 40
###begin p 41
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hhex</italic>
###xml 450 453 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syk</italic>
###xml 455 458 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lyn</italic>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycn</italic>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
A) Genes selectively expressed in LMO2-overexpressing patients from three human microarray analyses are shown. Below the first author citations are shown the number of patients in each study. The genes shown in red are retroviral insertions in the mouse Lmo2-clonal tumors. B) Select genes that were expressed in the LMO2-high class of patients were probed in the mouse tumors and are shown in the heat map. Several of these genes (e.g. Mef2c, Hhex, Syk, Lyn, Mycn) are differentially expressed in the mouse tumors in comparison to normal thymus and tumor 7065.
###end p 41
###begin p 42
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAP1</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAP1B</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAP1A</italic>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAPGEF5</italic>
###xml 161 169 161 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rap1gds1</italic>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Hussey1">[30]</xref>
###xml 402 410 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rap1gds1</italic>
###xml 467 472 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAP1B</italic>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAP1A</italic>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAPGEF5</italic>
###xml 659 668 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s005">Figure S5</xref>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
###xml 572 577 <span type="species:ncbi:9606">human</span>
Multiple RAP1 pathway genes also clustered with the LMO2-high group, including RAP1B, RAP1A and RAPGEF5. None are insertionally mutated in AKXD tumors, however, Rap1gds1 is insertionally mutated in tumor 98-031 and is the site of a recurrent chromosomal translocation in human T-ALL [30]. Rap1gds1 stimulates the exchange of GTP for GDP on Rap1 and is an activator of the Rap1 pathway. Upregulation of Rap1gds1 could therefore produce the same effect as upregulating RAP1B, RAP1A or RAPGEF5. Pathway analysis on genes shared in at least two microarray datasets (mouse and human combined) also suggested a role for cytokine signaling in tumor development (see Figure S5).
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tal1</italic>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lyl1</italic>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAL1</italic>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYL1</italic>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Ferrando1">[27]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Ferrando2">[31]</xref>
###xml 777 785 777 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIL-TAL1</italic>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 832 835 832 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina2">[3]</xref>
###xml 836 839 836 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Howe1">[5]</xref>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-DeKeersmaecker1">[32]</xref>
###xml 57 64 <span type="species:ncbi:9606">patient</span>
###xml 98 104 <span type="species:ncbi:10090">murine</span>
###xml 586 591 <span type="species:ncbi:9606">human</span>
###xml 632 639 <span type="species:ncbi:9606">patient</span>
###xml 692 699 <span type="species:ncbi:9606">patient</span>
To provide a better mechanistic understanding of SCID-X1 patient leukemias, we have analyzed five murine T-ALLs with insertional mutations at Lmo2. In each case these insertions are clonal. Therefore, they must have occurred early in tumor induction, similar to four of the five cases of gene therapy-induced leukemias. Transcriptional profiles of these T-ALLs showed high expression of the Tal1 and Lyl1 oncogenes as well as other Lmo2-binding partners such as Gata1 and Gata2. TAL1 and LYL1 are class II bHLH transcription factors that are frequently overexpressed along with LMO2 in human T-ALLs [27],[31]. Consistent with this, patient #4, who developed leukemia in the French trial, and patient #8, who developed leukemia in the English trial, showed rearrangement of the SIL-TAL1 loci along with insertional activation of LMO2[3],[5],[32].
###end p 44
###begin p 45
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 277 280 277 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Nam1">[6]</xref>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 418 424 <span type="species:ncbi:10090">murine</span>
###xml 487 493 <span type="species:ncbi:10090">murine</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
Murine T-ALLs with Lmo2 insertions also showed consistent downregulation of genes activated by E2A and upregulation of genes repressed by E2A, consistent with previous studies suggesting that Lmo2 redirects E2A activity by binding it through its partner proteins, Tal1 or Lyl1 [6]. Genes that are activated by the Lmo2/Tal1/E2A/Gata1-containing complex in normal erythrocyte development were also overexpressed in one murine T-ALL with high Gata1 expression. These findings suggest that murine T-ALLs with Lmo2 insertions resemble human T-ALLs that are initiated by LMO2 deregulation.
###end p 45
###begin p 46
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dave1">[9]</xref>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 571 577 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
Our high throughput insertion site analysis identified additional disease-related genes that are likely to cooperate with Lmo2 in leukemia induction. We identified a second tumor (7107), in addition to tumor (98-031) described previously [9] that has an Il2rg insertion. Remarkably, this tumor has two insertions at Il2rg that occurred independently suggesting strong selection for Il2rg deregulation in Lmo2-initiated T-ALL. In addition, tumor (7065) has insertions in Notch1 and Il2rg, suggesting that Il2rg might be able to cooperate with other T-cell oncogenes (i.e. Notch1) in leukemia induction.
###end p 46
###begin p 47
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rb</italic>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 694 699 694 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Shou1">[33]</xref>
###xml 758 762 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Woods1">[34]</xref>
###xml 868 872 868 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 894 898 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 974 983 974 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000491.s005">Figure S5</xref>
###xml 1183 1188 1183 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1197 1201 1197 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 1253 1257 1253 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 1435 1439 1435 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Johnston1">[18]</xref>
###xml 1440 1444 1440 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Oakes1">[35]</xref>
###xml 1558 1563 1558 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 1606 1610 1606 1610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 431 446 <span type="species:ncbi:10090">transgenic mice</span>
###xml 843 849 <span type="species:ncbi:10090">murine</span>
###xml 888 893 <span type="species:ncbi:9606">human</span>
###xml 1133 1148 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1161 1167 <span type="species:ncbi:10090">murine</span>
###xml 1219 1225 <span type="species:ncbi:10090">murine</span>
The newly identified insertions are also close to or within the Med12 gene. Similar to Il2rg, this gene is not activated or downregulated by the insertions. We favor Il2rg as the retroviral target since the RTCGD is replete with common insertions in cytokine receptors that act in the exact same pathway as Il2rg. More recently, we have found Il2rb is a common insertion site in a retroviral insertional mutagenesis screen in Lmo2 transgenic mice (U.P. Dave, unpublished observation). Other Il2rg binding partners, Il7ra and Jak1, were insertionally activated in the same screen which has not reached saturation. While still somewhat controversial, two studies provide additional evidence that Il2rg can function as an oncogene under some circumstances [33],[34]. A statistically significant enrichment of Il2rg-dependent cytokine pathways in murine T-ALLs containing Lmo2 insertions and human LMO2-overexpressing T-ALLs was also observed by Ingenuity pathway analysis (see Figure S5). A role for these pathways in T-ALL is further supported by studies showing that cytokines, which depend on Il2rg for signaling can induce T-ALL in transgenic mice, and by the murine T-ALL with two Il2rg and two Irs2 insertions. This murine T-ALL is significant since Irs2 encodes a protein adaptor that is phosphorylated by JAK3 tyrosine kinase in response to cytokine ligation by Il2rg and its heterodimeric partners such as Il7ra, Il4ra and Il9ra [18],[35]. The occurrence of leukemias in the SCID-X1 gene therapy trials also lends compelling support to the notion that IL2RG is oncogenic and a cooperating "hit" with LMO2.
###end p 47
###begin p 48
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Reicin1">[36]</xref>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Bellacosa1">[37]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Sauvageau1">[38]</xref>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RG</italic>
###xml 323 326 323 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Howe1">[5]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina3">[11]</xref>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Shou1">[33]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-ASGCT1">[39]</xref>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Woods1">[34]</xref>
###xml 747 752 747 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 803 808 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Shou1">[33]</xref>
###xml 1117 1122 1117 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1314 1318 1314 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 1373 1377 1373 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 1400 1406 1400 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
Il2rg expression was not upregulated in any of these three tumors but there is precedent for cancer genes being dysregulated without gross overexpression or at specific developmental stages [36],[37],[38]. Similarly, the IL2RG transgene was not overexpressed in patients receiving gene therapy or in those developing T-ALL [5],[11]. We theorize that a gene is less able to be silenced if there is a nearby retroviral insertion. Enforced expression of Il2rg has been shown to cause T-cell leukemias without gross overexpression [33],[39]. In the study by Woods et al, they specifically remark that transgene levels in thymic lymphomas were comparable to Il2rg expression levels seen in developing thymi [34]. Another compelling possibility is that Il2rg is misexpressed in a target cell population where Il2rg is not normally found such as a cell more primitive than a thymocyte precursor. The study by Shou et al presents an alternate hypothesis that the SCID-X1 background is required for leukemia development perhaps due to altered numbers of hematopoietic precursors or stem cells [33]. It may be that the lack of Il2rg creates a differentiation block that expands a cell type that is susceptible to transformation. Recurrent insertions in genes that are also CIS in the RTCGD were identified by Shou et al but Lmo2 was not one of them. The tumors were not analyzed for Lmo2 overexpression or for Notch1 activating mutations. Our data suggests that leukemia requires many "hits" and in their model somatic mutation in cooperating oncogenes or tumor suppressor genes may be more likely than insertional mutation since their vector was replication-defective.
###end p 48
###begin p 49
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Deichmann1">[4]</xref>
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Howe1">[5]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina3">[11]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Schwarzwaelder1">[40]</xref>
###xml 668 671 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;22</sup>
###xml 746 750 746 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMI1</italic>
###xml 867 871 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-HaceinBeyAbina3">[11]</xref>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 457 465 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 600 606 <span type="species:ncbi:10090">murine</span>
###xml 686 693 <span type="species:ncbi:9606">patient</span>
###xml 854 859 <span type="species:ncbi:10090">mouse</span>
Retroviral insertion site profiles have recently been published for the French and English cohorts of SCID-X gene therapy patients (n = 14) [4],[5],[11],[40]. Presently, there is no statistical difference between the incidence of leukemia in the French (4 of 10) and English patients (1 of 10) and with long term follow-up, even the insertion site profiles may be quite similar in the two studies. Comparison of the insertion sites identified in the French patients with those in RTCGD showed there was a statistically significant number of insertions in these patients, which are located at CISs in murine hematopoietic tumors (63/554, Fisher's exact test, p = 4.5x10-22). Remarkably, patient #10 of the French trial showed clonal insertions in LMO2 and BMI1; these two insertions were observed in tumor 98-031, underscoring the predictive power of our mouse models [11].
###end p 49
###begin p 50
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Cattoglio1">[41]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Ott1">[42]</xref>
###xml 753 761 753 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDS/EVI1</italic>
###xml 763 769 763 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRDM16</italic>
###xml 774 780 774 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SETBP1</italic>
###xml 959 963 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Du1">[19]</xref>
###xml 1121 1127 1121 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdm16</italic>
###xml 1191 1195 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
###xml 563 571 <span type="species:ncbi:9606">patients</span>
###xml 804 809 <span type="species:ncbi:10090">mouse</span>
###xml 1039 1047 <span type="species:ncbi:9606">patients</span>
###xml 1172 1178 <span type="species:ncbi:10090">murine</span>
In designing safer vectors for transduction, it will be important to consider self-inactivating LTRs and perhaps lentiviral backbones, which have different insertion site preferences than gamma-retroviruses, which may carry a lower risk of insertional mutation [41]. With the high transduction efficiencies achieved in these gene therapy trials, one could also see clonal expansion in cases where the transduced gene is not oncogenic. This, in fact, happened recently in two chronic granulomatous disease patients treated by retroviral gene therapy [42]. In both patients, a clonal expansion of the myeloid compartment was observed that began 3 to 5 months post-transplant. Clonal expansion was associated with insertional mutation of just three genes: MDS/EVI1, PRDM16, or SETBP1. Astonishingly, in the mouse, insertional mutation of these same genes has been associated with immortalization of early hematopoietic progenitor and/or myeloid progenitor cells [19]. Insertional mutations in these genes may have been selected in transplant patients due to their effects on increased self-renewal or engraftment potential. Prdm16 is also insertionally mutated in two of the murine T-ALLs with Lmo2 insertions so this gene's involvement in tumor induction might not be limited to the myeloid lineage.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
Ethics Statement
###end title 52
###begin p 53
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were aged in SPF facilities according to approved IACUC protocols at NCI-Frederick.
###end p 53
###begin title 54
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, Tumors, and DNA/RNA Preparation
###end title 54
###begin p 55
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Copeland1">[43]</xref>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Gilbert1">[44]</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dupuy1">[45]</xref>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 343 366 <span type="species:ncbi:11786">Murine leukemia viruses</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
Various AKXD strains were developed at the Jackson Laboratory. These are recombinant inbreds that have a high spontaneous rate of leukemia or lymphoma onset due to the presence of an endogenous retrovirus [43],[44]. The mice are viremic from birth and perhaps in utero and develop disease at various latencies, usually over six months of age. Murine leukemia viruses are not introduced. The mice are simply aged in SPF facility until the onset of disease. At the first appearance of morbidity, mice were sacrificed and gross necropsies performed. Organomegaly and abnormal features were noted and lymphoid and hematopoietic tissue was harvested and flash frozen in liquid nitrogen. Tissue was also fixed in formalin for immunohistochemistry. Frozen tissue was used in the preparation of high molecular weight DNA and whole RNA as previously described [45].
###end p 55
###begin title 56
Tumor Histochemistry and Southern Analysis
###end title 56
###begin p 57
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Gilbert1">[44]</xref>
###xml 234 236 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
Tumor genomic DNA was restriction digested and loaded on to agarose gels for overnight runs. The gels were transferred as described to Nitrocellulose (Amersham) [44]. Membranes were baked and UV-crosslinked. They were hybridized with 32P-labeled probes and exposed to film. For quantification, blots were exposed to phosphorimager plates and a Fuji phosphorimager used for quantitation. Details on probes used are available upon request. Paraffin-embedded tumors were sectioned and probed with a labeled BAC encompassing the mouse Irs2 gene. Labeling and FISH were performed by manufacturer's protocol (Vysis).
###end p 57
###begin title 58
Retroviral Insertion Site Cloning and Analysis
###end title 58
###begin p 59
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Suzuki2">[46]</xref>
###xml 125 128 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nla</italic>
###xml 135 138 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mse</italic>
###xml 183 186 179 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spe</italic>
###xml 345 348 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nla</italic>
###xml 355 358 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mse</italic>
###xml 405 409 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Dupuy1">[45]</xref>
###xml 1107 1112 1103 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1117 1121 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 1222 1227 1218 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf12</italic>
###xml 1524 1527 1520 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 1627 1635 1623 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1713 1715 1709 1711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 881 886 <span type="species:ncbi:10090">mouse</span>
Inverse PCR was performed as previously described [46]. For LM-PCR, tumor genomic DNA (1 microg) was digested overnight with NlaIII or MseI. The internal amplicon was eliminated by a SpeI digest. DNA was column purified (Amersham GFX) and ligated to a double stranded adaptor. This adaptor was made by annealing sense and antisense strands with NlaIII or MseI compatible overhangs as previously described [45]. The ligation mix was column purified (Qiagen) and then used for nested PCR. The PCR products were column purified and then ligated into pGEMT-Easy (Promega) plasmids and plated. Ninety six colonies were picked and miniprep DNA prepared using Whatman Ultra filters. Miniprep DNA was sequenced in 96 well format (Functional Biosciences) and files were analyzed in FASTA format. Valid sequences contained 3'LTR and adaptor at either end were then batch BLASTed against the mouse genome. Annotated insertions are posted at . Insertions were confirmed by either Southern analysis or PCR using gene-specific primers in the vicinity of insertions. For tumor 7107, gene specific primers corresponding to Il2rg and Irs2 were used in real time PCR (Biorad MyIQ) to confirm biclonality. For tumor 3095, virus-specific and Tcf12-specific primers were used in RT-PCR to generate cDNA for the viral-fusion transcript. 5'RACE was done using SMART Race kit (BD Biosciences) to verify that the transcriptional start site was in the virus. The full length cDNA was sequenced from both ends and TA-cloned into pGEMT-Easy (Promega); NotI digest released this cDNA for subcloning into pcDNA3.1 (Invitrogen). Orientation was verified and in vitro transcription and translation was performed using the TnT kit (Promega) with 35S-labeled methionine (Amersham). In vitro translated Tcf123095RIS was resuspended in RIPA buffer and immunoprecipitated using antibody against the COOH-terminus of Tcf12 (sc-357, Santa Cruz Biotechnology).
###end p 59
###begin title 60
###xml 28 33 <span type="species:ncbi:10090">Mouse</span>
Gene Expression Analyses of Mouse Tumors
###end title 60
###begin p 61
Tumors were homogenized in Trizol reagent (Sigma) and whole RNA was isolated by manufacturer's protocol. First strand cDNA was synthesized using oligo-dT primer and Superscript II or III reverse transcriptase enzymes (Invitrogen). Primers used for RT-PCR are available upon request. For real time PCR, we used Biorad's MyIQ or ABI 7700 machines with either Sybr green master mixes (Biorad) or Taqman probes (Applied Biosystems). Probe assays used are available upon request and were validated by Applied Biosystems. RNA was processed for hybridization to the Affymetrix chips according to standard protocols (see Text S1).
###end p 61
###begin title 62
###xml 23 28 <span type="species:ncbi:9606">Human</span>
Microarray Analyses of Human T-ALL Datasets
###end title 62
###begin p 63
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 852 856 852 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 916 920 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 936 940 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
Microarray analysis was performed with BRB-ArrayTools (version 3.2.3) developed by Biometric Research Branch at the National Cancer Institute. LMO2- positive and LMO2-negative tumors were compared by using univariate significance tests at the significance level of 0.001. The maximum false discovery proportions were restricted to 0.1 using multivariate permutation tests. As for the criteria of LMO2-positive and LMO2-negative tumors, there was no clear cut-off level for classifying a sample as having either high or low expression. We used artificial cut-off values to classify tumors into two groups. At first, we identified the median value of LMO2 expression signals as an initial indicator for the classification, and then we removed the marginal cases from the comparisons. For example, in the case of St Jude's data, we classified tumors with LMO2 signal>2000 as LMO2-positive group (13 cases), tumors with LMO2 signal<1000 as LMO2-negative group (14 cases).
###end p 63
###begin p 64
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Irizarry1">[47]</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000491-Wright1">[48]</xref>
Statistical comparison between tumor classes was done using the "BRB Array Tools" software (). We collated CEL file format of Affymetrix data by using the 'RMA' method [47] of the 'affy' package from BioConductor (). To identify genes that were differentially expressed among the two classes, we used a random-variance t-test. The random-variance t-test is an improvement over the standard separate t-test as it permits sharing information among genes about within-class variation without assuming that all genes have the same variance [48]. Genes were considered statistically significant if their p values were less than 0.001. A stringent significance threshold was used to limit the number of false positive findings. We also performed a global test of whether the expression profiles differed between the classes by permuting the labels of which arrays corresponded to which classes. For each permutation, the p values were re-computed and the number of genes significant at the 0.001 level was noted. The proportion of the permutations that gave at least as many significant genes as with the actual data was the significance level of the global test. We performed cluster analysis of genes and produced a heat map image to represent the over- and under-expression of each gene in each sample. We used quantile data ranges to ensure the even presence of all available colors on the map.
###end p 64
###begin p 65
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 28 33 <span type="species:ncbi:9606">human</span>
For comparison of mouse and human datasets, we used Fisher's exact test, binomial distribution and Chi-square tests to generate p values. Please see Text S1 regarding specific statistical questions analyzed.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tal1</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tal1</italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2A</italic>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 725 731 725 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 743 747 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ebf1</italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sfpi1</italic>
###xml 760 764 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flt3</italic>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 833 839 833 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hes1</italic>
###xml 950 955 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2ra</italic>
###xml 980 984 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ebf1</italic>
###xml 1062 1068 1062 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 1107 1113 1107 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 1287 1291 1287 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 1329 1334 1329 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata1</italic>
###xml 1339 1344 1339 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata2</italic>
###xml 1346 1351 1346 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata1</italic>
AKXD Lmo2 tumors co-express Tal1. A) quantitative RT-PCR shows Lmo2 and Tal1 are overexpressed in the tumors with respect to normal thymus. To the right are two heat maps from microarray expression data. B) This panel shows T-cell leukemia transcription factors and their expression in the Lmo2-clonal tumors. RNA from normal thymus and tumor 7065, which has a clonal, activating mutation in Notch1, are included in the comparison. Lmo2-clonal tumors have higher class II bHLH transcription factor expression and lower expression of E2A genes when compared to normal thymus and tumor 7065. C) This heat map shows documented Notch1 targets and their expression in the same tumors. All genes shown are normally up-regulated by Notch1 except for Ebf1, Sfpi1, and Flt3, which are repressed. The Lmo2-clonal tumors show low expression of Notch1 target genes and higher expression of genes that are repressed. Tumor 98031 has higher expression of Hes1 and Il2ra and lower expression of Ebf1, consistent with a heterozygous mutation in the heterodimerization domain of Notch1. The rest of the tumors had wild type Notch1 sequences. D) Experimentally confirmed Lmo2-binding partners are shown on this heat map. All of these were expressed at levels higher than normal thymus and tumor 7065. The Lmo2-clonal tumors had high expression of Gata1 and Gata2. Gata1 was very high in tumor 98031 and so we assayed the expression of erythroid genes in this tumor. E) Numerous erythroid genes were up-regulated in 98031. The genes denoted by the black arrows are activated by an Lmo2/Gata1/2/Tal1/E47/Ldb1-containing oligomeric complex that binds to promoter E box/Gata-motifs. Log2 intensity scales are shown for the heat maps.
###end p 67
###begin p 68
(2.29 MB TIF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LMO2</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
Human T-ALL microarray analysis shows representation of many CIS in the transcriptional profile of LMO2-overexpressing patients. Raw data were retrieved from three large published T-ALL studies and cases were clustered into LMO2-high expressing and LMO2-low expressing classes. We next sought to find the most statistically significant genes that clustered with the LMO2-high group. The studies' first authors are cited as well as the platforms used. In parentheses, we show how many probes were on the chip used. Below this, we show the number of CIS divided by the total number of genes that clustered with the LMO2-high expressing cases. The last number is the p value for identifying these CIS as calculated by Fisher's exact test.
###end p 70
###begin p 71
(2.78 MB TIF)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 643 648 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Med12</italic>
Il2rg insertions are clonal but cause no transcriptional activation. A) the structure of the genomic region with Il2rg and Med12 genes is shown. Yellow exons are coding and black arrows show transcriptional start sites and orientation. Southern analysis of tumor 7107 was done using NcoI digested tumor DNA. The germline band is identified by the arrow, G. The rearranged band is present with equal intensity and shown by the red asterisk. The size of the NcoI fragment did not allow discrimination between the two insertions in tumor 7107 since they were so close to each other. B) Primers were designed for quantitative RT-PCR for Il2rg and Med12 transcripts. The real time PCR data was normalized to thymus.
###end p 73
###begin p 74
(0.59 MB TIF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lmo2</italic>
###xml 810 815 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 869 870 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 879 881 879 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 908 909 908 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1154 1158 1154 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 1441 1445 1441 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 247 252 <span type="species:ncbi:10090">mouse</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
###xml 1115 1120 <span type="species:ncbi:10090">mouse</span>
###xml 1148 1153 <span type="species:ncbi:10090">mouse</span>
Tumor 7107 has one copy of Il2rg and two copies of Irs2 per cell. A) Primers were designed for a segment of genomic DNA 5' of the Il2rg gene and used to quantify copy number in tumor 7107. As control, genomic DNA was prepared from male and female mouse thymi. Ct values were plotted versus log (ng of gDNA). Equations and R2 values of the linear regression models are shown. Tumor 7107 QPCR shows similar trend to the male mouse consistent with one Il2rg copy per cell. Standard errors for each point represent triplicates and the experiment was performed twice. B) We applied QPCR to the other Lmo2-clonal tumors which were all female. Genomic DNA from tumor 3095 was unavailable. Ct values for 98031 were normalized to 1 for relative quantification. The results confirm that tumor 7107 was not polyploid for Il2rg gene. Standard errors are shown. Independent t-test (p = 5.3x10-5) and Mann-Whitney U-test (p = 0.02) both showed statistically significant difference between tumor 7107 and the other tumors. This confirms that all the tumors are diploid for chromosome X except for tumor 7107 which arose in a male mouse. C) A BAC encompassing the mouse Irs2 gene (chromosome 8) was labeled with Spectrum Orange and fluorescent in situ hybridization (FISH) performed on paraffin-embedded tumor. The section shown is completely involved with tumor cells and shows two signals for the labeled probe per cell. We did not find hyperdiploidy for Irs2 throughout the tumor.
###end p 76
###begin p 77
(2.16 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 673 674 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
Common gamma cytokine pathways are enriched in human and mouse T-ALL data sets. We combined human gene expression data with mouse insertion site profiles and performed Ingenuity pathway analysis. We identified a network of genes that were upregulated in at least two of the data sets. Statistical analysis of the Biocarta pathways present in this network is shown. The Ingenuity network contained 15 genes. List hits indicates how many of these were present in the specific Biocarta pathway. Population hits shows how many genes are present in the Biocarta pathway and Population total shows how many total genes are present in all of Biocarta at the time of our analysis. P values are calculated using Fisher's exact test.
###end p 79
###begin p 80
(2.81 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
This table shows a list of genes that are common to mouse and human leukemias.
###end p 82
###begin p 83
(0.02 MB XLS)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
Supplementary methods and results.
###end p 85
###begin p 86
(0.07 MB DOC)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 40 47 40 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000491-t001">Table 1</xref>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
This is a more comprehensive version of Table 1 which shows common insertion sites as well those insertions that are not CIS in the Retroviral Tagged Cancer Gene Database. If the gene has been implicated in human or mouse cancer, then the associated pathology is shown based on Sanger's Cancer Gene Census. Number of clones and frequency indicates how often an insertion appeared after shotgun cloning. It is calculated as the total identical clones divided by all informative clones found per tumor. Higher frequency indicates higher enrichment in the tumor genomic DNA.
###end p 88
###begin p 89
(0.04 MB XLS)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
We acknowledge the technical assistance of Debbie Gilbert, Debbie Householder, and Debbie Swing. We thank Linda Cleveland for assistance in sequencing. We thank Al Kane (SAIC, Frederick, MD) for graphics and illustrations.
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways.
###end article-title 93
###begin article-title 94
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
###end article-title 94
###begin article-title 95
###xml 51 59 <span type="species:ncbi:9606">patients</span>
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
###end article-title 95
###begin article-title 96
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.
###end article-title 96
###begin article-title 97
###xml 121 129 <span type="species:ncbi:9606">patients</span>
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.
###end article-title 97
###begin article-title 98
The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
###end article-title 98
###begin article-title 99
###xml 65 70 <span type="species:ncbi:9606">human</span>
Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
###end article-title 99
###begin article-title 100
###xml 35 40 <span type="species:ncbi:9606">human</span>
Transcription start regions in the human genome are favored targets for MLV integration.
###end article-title 100
###begin article-title 101
Gene therapy insertional mutagenesis insights.
###end article-title 101
###begin article-title 102
Gene therapy: is IL2RG oncogenic in T-cell development?
###end article-title 102
###begin article-title 103
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
###end article-title 103
###begin article-title 104
LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes.
###end article-title 104
###begin article-title 105
###xml 41 45 <span type="species:ncbi:10090">mice</span>
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2.
###end article-title 105
###begin article-title 106
Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential.
###end article-title 106
###begin article-title 107
An improved PCR method for walking in uncloned genomic DNA.
###end article-title 107
###begin article-title 108
New genes involved in cancer identified by retroviral tagging.
###end article-title 108
###begin article-title 109
###xml 12 17 <span type="species:ncbi:9606">human</span>
A census of human cancer genes.
###end article-title 109
###begin article-title 110
Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases.
###end article-title 110
###begin article-title 111
Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.
###end article-title 111
###begin article-title 112
Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.
###end article-title 112
###begin article-title 113
Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
###end article-title 113
###begin article-title 114
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas.
###end article-title 114
###begin article-title 115
Molecular genetics of acute lymphoblastic leukemia.
###end article-title 115
###begin article-title 116
Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.
###end article-title 116
###begin article-title 117
###xml 115 139 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells.
###end article-title 117
###begin article-title 118
Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development.
###end article-title 118
###begin article-title 119
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
###end article-title 119
###begin article-title 120
###xml 98 106 <span type="species:ncbi:9606">patients</span>
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.
###end article-title 120
###begin article-title 121
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.
###end article-title 121
###begin article-title 122
The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia.
###end article-title 122
###begin article-title 123
Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
###end article-title 123
###begin article-title 124
Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia.
###end article-title 124
###begin article-title 125
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy.
###end article-title 125
###begin article-title 126
Gene therapy: therapeutic gene causing lymphoma.
###end article-title 126
###begin article-title 127
Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.
###end article-title 127
###begin article-title 128
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice.
###end article-title 128
###begin article-title 129
###xml 60 89 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Effects of provirus integration in the Tpl-1/Ets-1 locus in Moloney murine leukemia virus-induced rat T-cell lymphomas: levels of expression, polyadenylation, transcriptional initiation, and differential splicing of the Ets-1 mRNA.
###end article-title 129
###begin article-title 130
Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia.
###end article-title 130
###begin article-title 131
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.
###end article-title 131
###begin article-title 132
###xml 39 44 <span type="species:ncbi:9606">human</span>
Hot spots of retroviral integration in human CD34+ hematopoietic cells.
###end article-title 132
###begin article-title 133
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
###end article-title 133
###begin article-title 134
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse as a gene discovery tool in the modern genome era.
###end article-title 134
###begin article-title 135
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Susceptibility of AKXD recombinant inbred mouse strains to lymphomas.
###end article-title 135
###begin article-title 136
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system.
###end article-title 136
###begin article-title 137
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice.
###end article-title 137
###begin article-title 138
Summaries of Affymetrix GeneChip probe level data.
###end article-title 138
###begin article-title 139
A random variance model for detection of differential gene expression in small microarray experiments.
###end article-title 139
###begin p 140
The authors have declared that no competing interests exist.
###end p 140
###begin p 141
This work was supported by the American Cancer Society institutional grant (#IRG-58-009-48), the Sartain-Lanier Family Foundation, the T.J. Martell Foundation, and Hope Street Kids to UPD. UPD was also supported by a Vanderbilt Physician Scientist Development award and the National Heart, Lung and Blood Institute grant 1K08HL089403-01. SMC was supported by a training grant from the National Cancer Institute 5T32CA009385-25. All microarray experiments were performed in the Vanderbilt Microarray Shared Resource, which is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485), the Vanderbilt Digestive Disease Center (P30 DK58404) and the Vanderbilt Vision Center (P30 EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 141

